An Exploration of Business Model Components in Biopharmaceutical Companies

• Váldodahkkit: Maryam Goodarzi (Dahkki), Seyed Soroush Ghazinoori (Dahkki), Reza Radfar (Dahkki), Abbas Kebriaeezadeh (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Tehran University of Medical Sciences, 2020-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background and Aim: Given the increasing variety of biological drugs in the world and the significant role of these drugs in patientschr('39') quality of life, as well as the high risk of drug productions, biopharmaceutical companies need to revise their business model. The purpose of this...